Important Safety Information
Medication Guide and Prescribing Information
DYANAVEL XR Liquid Tris ADHD medication
Tris Pharma DYANAVEL XR Boy working on test
For patients 6 years and older with ADHD

DYANAVEL® XR liquid results: Attention Measurement Test

*

Learn about a clinical study with children that took DYANAVEL XR (amphetamine) compared to those children that took a sugar syrup

See how DYANAVEL XR Liquid works fast and lasts.1

PERMP scores were significantly better with DYANAVEL XR for up to 13 hours postdose vs placebo2

Change from predose in number of problems attempted

Change from predose in number of problems attempted chart

Change from predose in number of problems answered correctly

Change from predose in number of problems answered correctly chart
Tris Pharma ADHD Chart Legend
  • One of the secondary endpoints was change from predose PERMP scores at 1, 2, 4, 6, 8, 10, 12, and 13 hours postdose2
  • PERMP is a 10-minute written test with the number of problems attempted and the number of problems answered correctly used as measures of a patient’s performance2
  • PERMP scores (problems attempted and problems answered correctly) were significantly improved with DYANAVEL XR (amphetamine) at all postdose time points compared with placebo (P<0.0001 for both)2

The study was performed in a laboratory classroom setting with children ages 6 to 12 with ADHD

At the end of each week, teachers and raters used a rating scale to evaluate the attention and behavior of the children who took DYANAVEL XR against the children taking the sugar syrup.

The Attention Test is a two-part test. It measures a child’s scores on:

  • the number of problems attempted, and
  • the number of problems solved accurately

Addition of the scores from each part provides that child’s Total Score on the Attention Test.

Higher Total Scores on the Attention Test reflect the child’s ability to pay attention for 10 minutes straight when seated in one place.

Using the Attention Test as a tool to measure the clinical benefit of an ADHD treatment in late-stage clinical studies is an objective way to measure the ability of a person with ADHD to pay attention and complete a task.

The Attention Test is
made up of two parts:

  • Each part is a single page of 80 different addition and subtraction problems, chosen based on results from a practice test administered to each child
  • The first part measures the child’s ability to focus on and attempt to solve as many addition and subtraction problems from those assigned
  • The second part measures the child’s ability to accurately answer a different set of such problems

Real results

Shown here are examples of an actual completed Attention Test with the same child, one with DYANAVEL XR, one with a sugar syrup.

Both tests were conducted at the same timepoint of the day, 1 hour after the treatment was administered to the child.

Sugar syrup at 1 hour

Test result Sugar syrup at 1 hour

DYANAVEL XR at 1 hour

Test result DYANAVEL XR at 1 hour

As illustrated here, patients who took DYANAVEL XR attempted and solved more problems than those who took the sugar syrup at this timepoint.

Did you know...?

Dosing options for DYANAVEL XR can be adjusted in small amounts as prescribed by your doctor and directed by your pharmacist.

tris pharma DYANAVEL XR ADHD medicine

Did you know you may be able to SAVE on a DYANAVEL XR prescription?**

liquixr logo
Eligible patients may
pay as little as $25
Get savings card
Or text TRIS to TRIS4U (874748) for a Mobile Savings Card.
tris pharma ADHD medication kids playing on playground

* Term for the Permanent Product Measurement of Performance test used in clinical trials of ADHD.

In a clinical study performed in a laboratory classroom, DYANAVEL XR was found effective at reducing the symptoms of ADHD and improving performance in children ages 6-12 years at all measured times (1, 2, 4, 6, 8, 10, 12, and 13 hours after taking) compared to a sugar syrup.

** Co-pay offer is subject to eligibility. Terms and Conditions apply.

Mobile Terms and Conditions: coupon.trisadhd.com/terms. Message data rates may apply.

References: 1. Pardo A, Kando JC, King TR, Rafla E, Herman BK. CNS Spectr. 2020;25(6):774-781. 2. Childress AC, Wigal SB, Brams MN, et al. J Child Adolesc Psychopharmacol. 2018;28(5):306-313.

Important Safety Information & Approved Use

DYANAVEL® XR (amphetamine), Quillivant XR® (methylphenidate HCI), and QuilliChew ER® (methylphenidate HCI) are federally controlled substances (CII) because they can be abused or lead to dependence. Keep these medicines in a safe place to prevent misuse and abuse. Selling or giving away these medicines may harm others and is against the law. Tell your doctor if you, your child, or any family members have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

See Additional Important Safety Information.

Important Safety Information & Approved Use

DYANAVEL® XR (amphetamine), Quillivant XR® (methylphenidate HCI), and QuilliChew ER® (methylphenidate HCI) are federally controlled substances (CII) because they can be abused or lead to dependence. Keep these medicines in a safe place to prevent misuse and abuse. Selling or giving away these medicines may harm others and is against the law. Tell your doctor if you, your child, or any family members have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

DYANAVEL XR, or Quillivant XR and QuilliChew ER, should not be taken if you or your child are allergic to amphetamine or methylphenidate hydrochloride, respectively, or any of the ingredients in these medicines, or are taking or have taken within the past 14 days an anti-depression medicine called a monoamine oxidase inhibitor or MAOI.

DYANAVEL XR, Quillivant XR, and QuilliChew ER can cause serious side effects. Tell the doctor:

  • if you or your child have heart problems, heart defects, high blood pressure, or a family history of these problems. This is important because sudden death has occurred in children 6 to 17 years old with heart problems or defects, and sudden death, stroke, and heart attack have happened in adults. Your doctor should check you or your child carefully for heart problems before starting any of these medicines. Since increases in blood pressure and heart rate may occur, the doctor should regularly check these during treatment. Call the doctor right away if you or your child have any signs of heart problems such as chest pain, shortness of breath, or fainting while taking any of these medicines.
  • if you or your child have mental problems, or a family history of suicide, bipolar illness, or depression. This is important because new or worsening behavior and thought problems or bipolar illness may occur. New symptoms such as seeing or hearing things that are not real, believing things that are not true, being suspicious, or having new manic symptoms may occur. Call the doctor right away if there are any new or worsening mental symptoms during treatment.
  • if you or your child have circulation problems in fingers and toes (called peripheral vasculopathy, including Raynaud’s phenomenon). Fingers or toes may feel numb, cool, painful, sensitive to temperature, and/or change color from pale, to blue, to red. Call the doctor right away if any signs of unexplained wounds appear on fingers or toes while taking DYANAVEL XR, Quillivant XR, or QuilliChew ER.
  • if your child is having slowing of growth (height and weight); Your child should have his or her height and weight checked often while taking DYANAVEL XR, Quillivant XR, or QuilliChew ER.
  • if you or your child develop painful and prolonged erections (priapism), seek medical help right away. Priapism has occurred with methylphenidate (Quillivant XR and QuilliChew ER). Because priapism can cause long-lasting damage, it should be checked by a doctor right away.
  • if you or your child have symptoms of serotonin syndrome - agitation, hallucinations, coma, or other changes in mental status; fast heartbeat; sweating or fever; nausea, vomiting, diarrhea; high or low blood pressure; problems controlling movements or muscle twitching; muscle stiffness or tightness. Serotonin syndrome may occur when DYANAVEL XR is taken with certain other medicines and may be life-threatening. Stop DYANAVEL XR and call your doctor or go to the nearest hospital emergency room.
  • if you or your child have phenylketonuria (PKU). QuilliChew ER contains phenylalanine as part of the artificial sweetener, aspartame. The artificial sweetener may be harmful to people with PKU or who are allergic to phenylalanine.
  • if you or your child are pregnant or plan to become pregnant. It is not known if DYANAVEL XR, Quillivant XR, or QuilliChew ER will harm your unborn baby. Tell your doctor if you or your child become pregnant during treatment with any of these medicines.
  • if you or your child is breastfeeding or plan to breastfeed. DYANAVEL XR, Quillivant XR, and QuilliChew ER pass into breast milk. You or your child should not breastfeed while you are taking any of these medicines.

Common side effects of amphetamine products include:

  • dry mouth
  • nausea
  • extreme mood changes
  • decreased appetite
  • trouble sleeping
  • dizziness
  • weight loss
  • restlessness
  • increased heart rate
  • stomach pain

Common side effects of methylphenidate products inlude:

  • decreased appetite
  • stomach pain
  • irritability
  • trouble sleeping
  • weight loss
  • mood swings
  • nausea
  • anxiety
  • fast heart beat
  • vomiting
  • dizziness
  • increased blood pressure
  • indigestion

Talk to your doctor if you or your child have any side effects that bother you or do not go away.

Avoid drinking alcohol while taking DYANAVEL XR, Quillivant XR, or QuilliChew ER.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

APPROVED USE

DYANAVEL XR, Quillivant XR, and QuilliChew ER are central nervous system (CNS) stimulant prescription medicines used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years and older. These medicines may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD.

It is not known if DYANAVEL XR, Quillivant XR, and QuilliChew ER are safe and effective in children under 6 years of age.

See Medication Guide for DYANAVEL XR, Quillivant XR, and QuilliChew ER.

See Full Prescribing Information for DYANAVEL XR, Quillivant XR, and QuilliChew ER, including Boxed Warning about Abuse and Dependence.

up arrowTop